Abstract
Catheter ablation for atrial fibrillation in patients with heart failure with reduced ejection fraction is associated with improvement in patient-centered outcomes, such as mortality, heart failure readmission, and atrial fibrillation recurrence, compared with standard medical therapy with or without device therapy. The evidence is not as robust in patients with atrial fibrillation and heart failure with preserved ejection fraction.
Original language | English (US) |
---|---|
Pages (from-to) | 185-195 |
Number of pages | 11 |
Journal | Cardiology clinics |
Volume | 37 |
Issue number | 2 |
DOIs | |
State | Published - May 2019 |
Keywords
- Atrial fibrillation
- Catheter ablation
- Heart failure hospitalization
- Mortality
- Pharmacologic therapy
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine